Framework contracts for innovative infectious disease therapeutics
Original notice title
Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases
Opportunity Score
Why this score?
Opportunity
72 / 100
Complexity
88 / 100
Risk factors
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
- Country
- Belgium
- CPV
- 73000000 - Research and development services and related consultancy services +1 more
- Deadline
- Sep 02, 2026
- Estimated value
- EUR 252M
Overview
Moderate opportunityKey Facts
- EUR 252M estimated value
- Framework procurement
- Services contract
- 2 lots
- Development of innovative next-generation therapeutics for infectious diseases under competitive development phases within a Pre-Commercial Procurement model.
- Potential treatment areas include viral infections, infection-related acute respiratory distress syndrome, and sepsis.
Show full summary
HaDEA is procuring two EU-funded framework service lots under a competitive phased Pre-Commercial Procurement procedure for innovative next-generation therapeutics for infectious diseases. The scope includes pathogen-targeted and host-targeted therapeutics, combination therapies, alternative administration routes, and therapies addressing viral infections, infection-related ARDS or sepsis. The total estimated value is EUR 252,000,000. Electronic submission through the Funding and Tenders Portal is required by 2 September 2026 at 14:00:59 UTC. The opportunity is substantial but requires detailed review of procurement documents that were not provided or analyzed.
Risks
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- The procurement uses a competitive development in phases under Pre-Commercial Procurement and is structured as framework contracts.
Administrative
- Two lots are available and the notice states that a tenderer may submit for and be awarded a maximum of two lots.
- Electronic submission is required through the Funding and Tenders Portal submission endpoint.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Buyer
Location
Brussels, BEL
Website
Identifier
HADEA
Activity
General public services
Lots (2)
LOT-0001
Highly Innovative Therapeutics
Framework service lot for pathogen-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.
EUR 252M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Please consult the procurement documents.
Additional CPV codes
Value note
Show original TED data
Original TED description
Lot 1 targets pathogen targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
LOT-0002
Advanced Therapeutics
Framework service lot for host-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.
EUR 252M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Please consult the procurement documents.
Additional CPV codes
Value note
Show original TED data
Original TED description
Lot 2 targets host targeted scalable therapeutics, innovative combination therapies and therapeutics designed to be administered through alternative routes to IV
Procurement Details
- Publication date
- 01 Jul 2026
- Languages
- English, Bulgarian
Reference metadata
- Legal basis
- 32024R2509
Reference IDs
- Tender ID
- 456593-2026
Documents (2)
Similar tenders
Norway – Research and development services and related consultancy services – Migration decisions on Norway
Norway – Research and development consultancy services – Framework agreement for assistance with the work of following and evaluating the system for competence and career development for employees in nurseries and schools.
Netherlands – Research and development consultancy services – Tender for a bilateral NL-UK quantum technology End-user engagement Programme
Norway – Advisory and consultative engineering services – Procurement of a feasibility study for the assessment of raising U-864
Belgium – Research and experimental development services – Assistance mechanism on Maritime Spatial Planning (MSP)
Poland – Design and execution of research and development – Kompleksowa usługa CRO (Contract Research Organization) w niekomercyjnym badaniu klinicznym w ramach Projektu pod nazwą „Nowatorskie terapie genowe w leczeniu choroby Parkinsona oraz innych zaburzeń neurodegeneracyjnych”
Opportunity Score
Why this score?
Opportunity
72 / 100
Complexity
88 / 100
Risk factors
The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...
The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications